[Skip to Navigation]
Editorial
December 2, 2020

Removal of Race From Estimates of Kidney Function: First, Do No Harm

Author Affiliations
  • 1Division of General Internal Medicine, David Geffen School of Medicine, Los Angeles, California
  • 2Renal-Electrolyte and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia
  • 3Division of General Internal Medicine, Duke University School of Medicine, Durham, North Carolina
JAMA. 2021;325(2):135-137. doi:10.1001/jama.2020.23373

Chronic kidney disease (CKD) is a major public health problem, and it provides an important example of health disparities in the US. Black individuals are 2 to 4 times more likely than others to progress to kidney failure and are less likely to receive optimal therapies, including kidney transplants. Reasons that contribute to these disparities include a variety of factors that are a direct result of structural racism, including poor access to health care, low educational attainment, and poverty.1-3

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    ×